For U.S. Healthcare Professionals OnlySign Up Now
Register for news and exclusive offers. Fill out the form below to stay up-to-date on the latest information about Nasacort Allergy 24HR and other Chattem products.
Allergic rhinitis is an inflammatory response by the body's immune system, and involves early and late phases. When a patient inhales an allergen, the body reacts immediately, releasing histamines and other chemical mediators within the nasal membrane. Nasal allergy symptoms like runny nose, itchy nose, and sneezing then appear (early-phase response). Hours later, specialized white blood cells (eosinophils, lymphocytes) arrive, increasing tissue inflammation and mucus production. This escalates symptoms—especially congestion (late-stage response). Add the early phase to this late-stage response, and you have a perpetuating allergic cascade. This escalating allergic response can be stopped with intranasal steroid (INS) treatment.1
According to the latest medical guidelines, INSs are the most effective class for controlling symptoms.2
Note: This chart represents leading allergy medicines in each category of treatment and is not intended to represent an all-inclusive list. Use only as directed. Please see specific product packaging for complete instructions for use.
References: 1. Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010; 81(12):1440-1446. 2. Wallace DV, Dykewicz MS, Bernstein DI, et al; Joint Task Force on Practice; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(suppl 2):S1-S84.
Use only as directed. For complete directions, warnings, and other information, please see the Drug Facts Label.
A: Nasacort Allergy 24HR is an over-the-counter intranasal steroid (INS) used to treat nasal symptoms of indoor and outdoor allergies (perennial and seasonal allergic rhinitis). When Nasacort is used as directed, it can relieve the symptoms of allergic rhinitis: sneezing, runny nose, nasal itching, and congestion. Nasacort is not for children under 2 years of age.
A: Nasacort Allergy 24HR will be available without a prescription in stores nationwide in spring 2014.
A: The price of Nasacort Allergy 24HR is at the discretion of each retailer, and will be priced comparably with other over-the-counter allergy brands.
A: Yes, Nasacort Allergy 24HR and Nasacort AQ are the same medicine. Nasacort Allergy 24HR has the same prescription strength as Nasacort AQ without a prescription.
A: Nasacort Allergy 24HR temporarily relieves these symptoms of hay fever or upper respiratory allergies in patients age 2 and older:
A: Yes, when used as directed, Nasacort Allergy 24HR is safe to use every day.
A: Patients should ask their doctor or healthcare provider about using other allergy medications in conjunction with Nasacort.
A: Yes, Nasacort Allergy 24HR is safe to use with blood pressure medicines.
A: No, Nasacort Allergy 24HR is formulated to be non-drowsy.
A: No, Nasacort Allergy 24HR is scent-free.
A: No, Nasacort Allergy 24HR is formulated to be drip-free.
A: The most common side effects of Nasacort Allergy 24HR include sore throat, headache, and epistaxis (nosebleeds). Patients should be encouraged to read the Drug Facts Label for full warnings, including pediatric growth information.
A: According to the latest medical guidelines,1 allergy symptoms are measured by how significantly a patient’s quality of life has been affected by sneezing, itching, runny nose, or nasal congestion. In moderate to severe cases, one or more of the following characteristics should be present:
A: When allergens enter the body, the immune system immediately reacts, releasing histamine, cytokines, and other chemicals (early-phase response). Nasal allergy symptoms like runny nose, itchy nose, sneezing, and congestion are then triggered. These symptoms can lead to tissue inflammation, which increases irritation and leads to more chemicals and mediators being released (late-phase response). This escalating cycle of inflammation and symptoms – or allergic cascade – can be stopped with an INS.
A: Oral antihistamines (OAHs) work in the early stages of the allergic cascade to target the body's histamine response to allergens. They do a good job of treating mild to moderate nasal allergy symptoms, but OAHs do not treat nasal congestion. INSs, like Nasacort Allergy 24HR, target both early and late stages of the allergic cascade to treat moderate to severe symptoms, including nasal congestion. Treatment guidelines1 state INSs are the most effective class of medication in controlling symptoms of allergic rhinitis.
A: While oral decongestants can help with congestion, they do not address other allergic rhinitis symptoms such as sneezing, runny nose, and itchy nose. Additionally, because oral decongestants have systemic vasoconstrictive properties, patients receiving them should be monitored for changes in blood pressure. INSs such as Nasacort Allergy 24HR can help clear up the full range of allergic rhinitis symptoms, including nasal congestion, for 24 hours. It may take up to one week of daily use for the most symptom relief.
A: Intranasal decongestants cause localized vasoconstriction within the nasal membrane, which quickly relieves nasal congestion. However, they have no effect on itching, sneezing, or nasal secretion. Plus, they should only be used occasionally, over short periods of time (3 to 5 days is recommended) because of the risk of rebound congestion. INSs such as Nasacort Allergy 24HR can help clear up the full range of allergic rhinitis symptoms, including nasal congestion, for 24 hours. It may take up to one week of daily use for the most symptom relief.
Reference: 1. Wallace DV, Dykewicz MS, Bernstein DI, et al; Joint Task Force on Practice; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(suppl 2):S1-S84.
Welcome and thank you for visiting this website, which is owned and operated by Chattem, Inc. ("Chattem"). Chattem maintains this website as a service to those in the internet community who are interested in its products, and it is intended to be informative, useful and fun. Access to and use of this website are subject to and governed by the terms and conditions set forth in it and all applicable laws. Chattem may revise these terms and conditions from time to time, without notice, by updating this posting. Please use the Contact Us link if you have any questions, comments or concerns regarding this website.
The following are terms and conditions that apply to your use of this website. BY USING THIS WEBSITE OR DOWNLOADING MATERIALS FROM THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS SET FORTH BELOW AS IF YOU HAD FORMALLY SIGNED AND AGREED TO THEM IN WRITING. If you do not agree with any of these terms or conditions, please do not use this website.
You acknowledge and agree that all content and material on this website ("Contents"), including, but not limited to, text and images, is protected by copyrights, trademarks, service marks, patents, trade secrets or other intellectual property rights and laws. The Contents are owned by Chattem, its affiliates, or other third parties from whom Chattem has licensed certain legal rights. All product names, whether or not appearing in large print or with the trademark symbol are trademarks of Chattem, its affiliates, related companies or its licensors or joint venture partners. Any use of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may violate without limitation, copyright law, trademark law, the law of privacy and publicity, and communications regulations statutes.
YOU EXPRESSLY AGREE THAT YOUR USE OF THIS WEBSITE IS AT YOUR SOLE RISK. THIS WEBSITE AND THE INFORMATION IT CONTAINS IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, CHATTEM EXPRESSLY DISCLAIMS ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT, OR ARISING FROM COURSE OF DEALING, USAGE OR TRADE PRACTICE. CHATTEM DOES NOT MAKE ANY WARRANTY OR REPRESENTATION THAT THIS WEBSITE WILL MEET YOUR REQUIREMENTS OR EXPECTATIONS, OR THAT THIS WEBSITE WILL BE UNINTERRUPTED, TIMELY, COMPLETE, SECURE, ERROR OR VIRUS FREE, OR THAT DEFECTS TO THIS WEBSITE, IF ANY, WILL BE CORRECTED. NOR DOES CHATTEM MAKE ANY WARRANTY OR REPRESENTATION REGARDING THE RESULTS THAT MAY BE OBTAINED FROM THE USE OF THIS WEBSITE, THE ACCURACY OR RELIABILITY OF ANY INFORMATION OBTAINED THROUGH THIS WEBSITE OR THE QUALITY OF ANY PRODUCTS, SERVICES, WEBSITES, INFORMATION OR OTHER MATERIAL OBTAINED BY YOU THROUGH THIS WEBSITE OR AS A RESULT OF THIS WEBSITE.
YOU EXPRESSLY UNDERSTAND AND AGREE THAT UNDER NO CIRCUMSTANCES SHALL CHATTEM, ITS AFFILIATES OR THEIR OFFICERS, DIRECTORS, EMPLOYEES OR AGENTS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES, INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF PROFITS, USE, DATA, GOODWILL OR OTHER INTANGIBLES ARISING OUT OF, OR INABILITY TO USE, THIS WEBSITE OR THE INFORMATION IT CONTAINS. THIS LIMITATION APPLIES WHETHER THE ALLEGED LIABILITY IS BASED ON LAW OR IN EQUITY, OR WHETHER ON CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY OR BASIS EVEN IF CHATTEM HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IF ANY OF THE ABOVE LIMITATIONS ARE VOID OR UNENFORCEABLE UNDER GOVERNING LAW, CHATTEM'S LIABILITY SHALL BE LIMITED TO THE FULLEST EXTENT PERMITTED BY LAW.
Upon a request by Chattem, you agree to defend, indemnify and hold harmless Chattem and its affiliates and their directors, officers, employees and agents against any claims, demands, actions, damages or other liabilities, including expenses and attorney's fees, that arise from your use of this website. Chattem reserves the right, at its own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification by you, in which event you will cooperate with Chattem in asserting any available defenses.
Any medical or health related information provided in this website is provided for educational purposes only and is not intended to constitute medical advice or replace discussions with a healthcare provider. You should not use the Contents of this website for diagnosing a health or fitness problem or disease, but should always consult a physician or medical advisor. All Chattem products should be used as directed in accordance with instructions provided on the packaging of the product. Before using any medication, read all label information and keep the carton. It contains important information.
Chattem controls and operates this website from the company's headquarters in Chattanooga, Tennessee. As a result, Chattem makes no representation that materials on this website are appropriate or available for use in locations outside the United States. Each claim or statement about effectiveness of Chattem products and/or each claim or statement comparing the effectiveness of Chattem products to the effectiveness of other products is expressly limited to the United States unless otherwise specified in the website. Accessing this website from territories where its content is illegal is prohibited. Those who choose to access this website from outside the United States do so on their own initiative and are responsible for compliance with all applicable local laws.
Any communications or information you transmit to this website by electronic mail or otherwise to Chattem shall be treated as non-confidential and non-proprietary. Although we welcome your comments and feedback with respect to this website or any of our products, we are not seeking and do not review any unsolicited ideas, suggestions or materials related to the development, design, manufacture or marketing of our products or the conduct of our business. This policy is intended to avoid confusion about the ownership of new ideas and concepts and to help protect you. By sending us any proposed ideas or other such information, you agree to transfer to Chattem all of your rights and interests in such proposed intellectual property, ideas and information. You further agree that any ideas, concepts or know-how that you or individuals acting on your behalf provide to Chattem can be used, reproduced, transmitted, disclosed or published by Chattem or its affiliates without restriction or compensation.
In general, we have designed this website to minimize the amount of personal information collected and request only the information that is required to ensure that visitors can effectively participate in our activities and events. No personal information is collected from visitors to this website unless you provide it to us voluntarily and knowingly. On this website, you may be able to enter contests, subscribe to services or otherwise respond to certain offers and opportunities. In order to accomplish this, it may be necessary for you to voluntarily provide some of the following types of personally identifiable information: name, address, e-mail address, telephone number, fax number, and information about your interests and use of various products, programs and services. We also may collect certain non-personally identifiable information when you visit one of our websites, as part of the standard operation of our server, by using Cookie Technology. This technology does not personally identify you or extract any information from your computer. Rather, Cookie Technology is used to provide an enhanced online experience, to measure and monitor the use of our website and to improve its design and content. The information this technology collects may include: the name of your Internet service provider, the date and time you accessed the website, the Internet address of the website from which you enter our website and where you go after you leave our website. Data that would personally identify you is known only when voluntarily submitted.
If you voluntarily provide us with any requested information, we generally use that information for internal purposes only. For example, we may use this information to communicate directly with you, such as to respond to your inquiries, to inform you when you have won one of our contests, or to offer you additional information about our products, programs, services, promotions or offers that we believe may be of interest to you. Such responses will include information on how to opt out from receiving further information or services. Certain information we receive online may on occasion be combined with our other records to enhance our ability to market those products or services we believe may be of interest to you. We never sell, rent or otherwise share any personal information we obtain with third parties, unless we have notified you at an e-mail address you provided that we intend to do so and have provided you with an opportunity to request that we not do so. We may have to disclose personally identifiable information in response to legal requests, for example court orders, subpoenas or specific requests from law enforcement agencies. Although we take appropriate measures to safeguard against unauthorized disclosures of information, we cannot assure you that personally identifiable information that we collect will never be disclosed in a manner that is inconsistent with this policy. We have, however, put in place appropriate physical, electronic and administrative safeguards to help prevent the unauthorized access and use of the information we collect online.
We do not knowingly collect personal information from children under the age of 13. If we learn that we have personal information on a child under the age of 13, we will delete that information from our systems. Chattem encourages parents to use the internet with their children. To make a child's online experience safer, we recommend that parents teach children never to give personal information, unless supervised by a parent or a responsible adult.
Keep an eye on your inbox. We'll be sending you Nasacort news, updates, and of course savings, starting soon.